跳至主要内容
临床试验/EUCTR2009-016092-30-AT
EUCTR2009-016092-30-AT进行中(未招募)不适用

THE PHARMACOKINETICS OF DAPTOMYCIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATIO

Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin0 个研究点开始时间: 2010年1月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age >18 years
  • - Suspected or proven bacterial infection requiring parenteral antibiotic therapy.
  • - Continuous venovenous hemofiltration because of an acute renal failure.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Known hypersensitivity to daptomycin.
  • - An expected survival of less than three days.
  • - Known pregnancy
  • - Patients being treated with daptomycin only regimen for diagnosis of osteomyelitis, meningitis, enterococci infection or pneumonia without adequate concomitant use of other more effective antimicrobial agents (as daptomycin is not indicated for primary treatment of these types of infections)

研究者

发起方
Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin

相似试验

THE PHARMACOKINETICS OF DAPTOMYCIN DURING CONTINUOUS... | 临床试验